5472-06-0 Usage
Uses
Used in Pharmaceutical Industry:
2-Butylamino-2-phenylacetic acid is used as a pharmaceutical intermediate for the synthesis of various drugs, particularly those with anti-inflammatory and analgesic properties. Its unique structure allows for the development of medications that can offer improved efficacy and safety profiles.
Used in Drug Modification:
2-butylamino-2-phenyl-acetic acid is utilized as a modifier in drug molecules to enhance their biological activity. By incorporating 2-butylamino-2-phenylacetic acid into pharmaceutical formulations, researchers can potentially create drugs with increased potency and reduced side effects, thus improving patient outcomes.
Used in Medicinal Applications:
The pharmacological properties of 2-butylamino-2-phenylacetic acid make it a valuable component in the development of new medications. Its versatility in drug synthesis and potential to contribute to the efficacy and safety of various treatments underscores its importance in advancing medical care.
Check Digit Verification of cas no
The CAS Registry Mumber 5472-06-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,7 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5472-06:
(6*5)+(5*4)+(4*7)+(3*2)+(2*0)+(1*6)=90
90 % 10 = 0
So 5472-06-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO2/c1-2-3-9-13-11(12(14)15)10-7-5-4-6-8-10/h4-8,11,13H,2-3,9H2,1H3,(H,14,15)
5472-06-0Relevant academic research and scientific papers
Nanda, Kausik K.,Trotter, B. Wesley
, p. 2025 - 2028 (2005)
A diastereoselective synthesis of pyrrolidine-derived arylglycines has been developed using the Petasis boronic acid Mannich reaction. High diastereoselectivities in the reactions of chiral amines, aryl boronic acids, and glyoxylic acid monohydrate have been demonstrated for the first time. Key to the implementation of this method is the discovery that hexafluoroisopropanol accelerates the Petasis process, reducing reaction times from multiple days to less than 24 h.
